This is what you said Anders:
“Then who do you think drafted the amended SAP? Dr Bosch? that would have been a red flag for the FDA. I dont see why Duffy could have not been that person, you dont explain why that would be a problem. He was hired and was an employee of NWBO and could do that job perfectly.
It would be inconceivable to change endpoints after they were unblinded. The FDA clearly states that the investigator identified the primary endpoints when they designed the trial should be removed when the amendment of the trial is drafted.”
It’s unbecoming to do that. No one”twisted” your words and from the beginning I agreed there would be consultations with everyone, they were all blinded, and he of course might be asked to read and review.
And yes, I have many decades of experience. Your attack and then claiming I “twisted” what you said to claim i victimized you is not cool. That quote is from a few posts earlier, in the conversation. People just have to see the responses.
Market Data 
Markets 
AI
